INTERCEPT PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Intercept Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q1 2022.
  • Intercept Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2022 was $7.76M, a 30.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 $7.76M -$3.4M -30.5% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $6.12M -$6.21M -50.4% Dec 31, 2021 10-Q 2022-05-06
Q3 2021 $7.51M -$2.54M -25.3% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $9.82M -$1.24M -11.2% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $11.2M -$1.28M -10.3% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $12.3M -$919K -6.94% Dec 31, 2020 10-K 2022-03-02
Q3 2020 $10.1M +$571K +6.02% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $11.1M +$159K +1.46% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $12.4M +$157K +1.28% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $13.2M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $9.48M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $10.9M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $12.3M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.